Buy Deciphera Pharmaceuticals Stock | DCPH Stock Price & Latest News | Public
DCPH

Deciphera Pharmaceuticals

$0.00 (0.00%)Today

    About DCPH

    Deciphera Pharmaceuticals, Inc. operates as a biotechnology company which develops and manufactures kinase inhibitor treatments for cancer by cutting off the ability of tumor cells to thrive and spread. The company designs a drug candidate, DCC-2618, to inhibit the full...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.45
    -0.91
    -1.36
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.15

    Actual EPS
    Q4 2020

    Stats

    Market Cap$3,51B
    Volume7,39k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$71.11
    1 Year Low$33.10
    Open$61.83
    High$62.27
    Low$61.59

    Buy any stock with any amount of money.

    Download the App
    Download the app